MedTrace Logo

Effects of EFT on Postpartum Safety Perception, Anxiety, and Postoperative Pain After Cesarean Section

NCT06999564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-16

No results posted yet for this study

Summary

This study is a parallel randomized controlled trial on 60 primiparous women with cesarean section pain, randomly divided into EFT and control groups. The study was approved by KTO Karatay University Faculty of Medicine Ethics Committee. Women will be included in the study according to the following criteria: at least primary school graduate, primiparous, planned cesarean section and 4 or more postoperative pain according to VAS. Women with chronic diseases such as heart disease, high blood pressure and diabetes, history of miscarriage, placenta previa, mental illness in the past year, psychoactive drug use, drug addiction, smoking, and pregnancy complications such as pre-eclampsia, bleeding, intrauterine death and preterm delivery will be excluded. Data collection will start in June 2025 and will be completed in August 2025.

Conditions

Interventions

BEHAVIORAL

EFT

EFT involves the following steps: 1. Identification of the problem that is causing the person distress (e.g., fear of childbirth) and scoring or measuring the severity of this problem. 2. Tapping with the fingertips on certain points of the face and body, known as correction (i.e., regulation of the energy system), as well as the expression of an emphatic phrase (related to the person\'s problem and self-acceptance).

Sponsors & Collaborators

  • KTO Karatay University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-02
Primary Completion
2025-12-01
Completion
2025-12-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06999564 on ClinicalTrials.gov